COVID-19: How should pharmacists play a role?

Dr Mary Bushell MPS, Prof Mark Naunton MPS, Distinguished Prof Greg Peterson FPS, Dr Shane Jackson FPS, A/Prof Chris Freeman FPS -
0
COVID-19
Clinical
Coronavirus (COVID-19) information for pharmacistsFor PSA’s latest information, updates and advice on the novel coronavirus outbreak, click here. Pharmacists, the most accessible healthcare professionals, are...

When iron reserves are running low

Ann Winkle MPS -
0
IV iron infusion used in iron deficiency anaemia treatment
CPD
Vivienne, a 78-year-old patient of yours, recently started an iron supplement for iron deficiency anaemia (IDA) diagnosed by her GP.

Opioid pharmacotherapy: delivery in community pharmacy

Chelsea Felkai MIPH MPS, Dr Glen Swinburne MPS, Dr Joyce Cooper & Assoc Prof Therese Kairuz MPS -
0
opioid substitution
Industry
The pharmacist’s guide to the different regulations and protocols across Australia. Opioid substitution has been recognised globally as an effective harm minimisation strategy for...

Closing the gap: Pharmacists in Aboriginal health

Jarryd Luke -
0
Closing the gap
Industry
Pharmacists working in Aboriginal Health Services (AHS), with the support of recent Government reforms, are playing a key role in closing the gap and...

Are nebulisers about to be smashed into obscurity?

Chloe Hava -
0
nebules
Industry
Pharmacists should brace for yet another medicine shortage. However, this one might actually be beneficial for patients.

GLP-1 RAs found to pose pregnancy risks

Chloe Hava -
0
GLP-1 RAs
Industry
Women of reproductive age using GLP-1 RAs could be at risk of unintended pregnancy, and unaware of the risks to pregnancy and unborn babies.
1...505152...321Page 51 of 321